New Reverdia patents strengthen licensing

Pivotal patents have been granted to DSM in Japan, Europe and Canada for its innovative yeast-based succinic acid production technology, with exclusive rights awarded to Reverdia. The new patents cover key technology, which is essential to make economically viable and sustainable bio-based succinic acid.
Reverdia President Marcel Lubben said, "Reverdia has developed and commercialised best-in-class, sustainable yeast-based bio-succinic acid technology, proven at commercial scale in our plant located within the Roquette Italian biorefinery. These latest patents are key to making bio-succinic acid commercially viable.”